{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T03:18:19Z","timestamp":1761621499532,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The top priority of clinical medicine center of Shanghai"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pseudotumour cerebri syndrome (PTCS) remains to be fully investigated in Chinese patients and our study reported PTCS-related clinical differences between Chinese patients and Western patients. This study enrolled 55 consecutive patients (females: 44, median age: 37\u2009y, age range: 14\u201362\u2009y) with PTCS diagnosed from October 2015 to December 2017. Nine (16.4%, females) patients had primary PTCS, and 46 (83.6%) had secondary PTCS (<jats:italic>P<\/jats:italic>\u2009=\u20090.001). At presentation, 81.8% of patients had grade &gt;3 papilloedema, with 23.6% having diffusely constricted fields. Mean subarachnoid space around the optic nerve measured by retrobulbar ultrasonography during lumbar puncture was 1.12\u2009\u00b1\u20090.17\u2009mm and decreased to 0.86\u2009\u00b1\u20090.11\u2009mm after treatment. Optical coherence tomography (OCT) showed that 92.9% of eyes with intact macular ganglion cell-inner plexiform layer (GCIPL) at baseline had good outcomes after treatment. Patients\u2019 demographic and clinical characteristics showed that secondary PTCS was more common than primary idiopathic intracranial hypertension in Chinese patients. Polycystic ovarian syndrome was the main associated factor in females. Poor visual function was common at presentation. Noninvasive ocular ultrasonography and OCT are the prognostic indicators of PTCS treatment in intracranial pressure and visual function, respectively, after PTCS treatment.<\/jats:p>","DOI":"10.1038\/s41598-020-58080-w","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T11:02:44Z","timestamp":1580122964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pseudotumour Cerebri Syndrome in China: A Cohort Study"],"prefix":"10.1038","volume":"10","author":[{"given":"Qian","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8789-936X","authenticated-orcid":false,"given":"Chaoyi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guixian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weimin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghuai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Sha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4277-1762","authenticated-orcid":false,"given":"Guohong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,27]]},"reference":[{"key":"58080_CR1","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/WNL.0b013e3182a55f17","volume":"81","author":"DI Friedman","year":"2013","unstructured":"Friedman, D. I., Liu, G. T. & Digre, K. B. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 81, 1159\u20131165 (2013).","journal-title":"Neurology."},{"key":"58080_CR2","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/jnnp-2011-302029","volume":"83","author":"V Biousse","year":"2012","unstructured":"Biousse, V., Bruce, B. B. & Newman, N. J. Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry. 83, 488\u2013494 (2012).","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"58080_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/ICU.0000000000000518","volume":"29","author":"G Madriz Peralta","year":"2018","unstructured":"Madriz Peralta, G. & Cestari, D. M. An update of idiopathic intracranial hypertension. Curr Opin Ophthalmol. 29, 495\u2013502 (2018).","journal-title":"Curr Opin Ophthalmol."},{"key":"58080_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(15)00298-7","volume":"15","author":"KA Markey","year":"2016","unstructured":"Markey, K. A., Mollan, S. P., Jensen, R. H. & Sinclair, A. J. Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol. 15, 78\u201391 (2016).","journal-title":"Lancet Neurol."},{"key":"58080_CR5","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1111\/j.1468-1331.2011.03372.x","volume":"18","author":"N Raoof","year":"2011","unstructured":"Raoof, N., Sharrack, B., Pepper, I. M. & Hickman, S. J. The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK. Eur J Neurol. 18, 1266\u20131268 (2011).","journal-title":"Eur J Neurol."},{"key":"58080_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1001\/archneur.1993.00540010072020","volume":"50","author":"K Radhakrishnan","year":"1993","unstructured":"Radhakrishnan, K., Ahlskog, J. E., Cross, S. A., Kurland, L. T. & O\u2019Fallon, W. M. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol. 50, 78\u201380 (1993).","journal-title":"Arch Neurol."},{"key":"58080_CR7","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/archneur.1988.00520320065016","volume":"45","author":"FJ Durcan","year":"1988","unstructured":"Durcan, F. J., Corbett, J. J. & Wall, M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol. 45, 875\u2013877 (1988).","journal-title":"Arch Neurol."},{"key":"58080_CR8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s004150070182","volume":"247","author":"I Yabe","year":"2000","unstructured":"Yabe, I., Moriwaka, F., Notoya, A., Ohtaki, M. & Tashiro, K. Incidence of idiopathic intracranial hypertension in Hokkaido, the northernmost island of Japan. J Neurol. 247, 474\u2013475 (2000).","journal-title":"J Neurol."},{"key":"58080_CR9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s10384-010-0907-9","volume":"55","author":"IH Liu","year":"2011","unstructured":"Liu, I. H., Wang, A. G. & Yen, M. Y. Idiopathic intracranial hypertension: clinical features in Chinese patients. Jpn J Ophthalmol. 55, 138\u2013142 (2011).","journal-title":"Jpn J Ophthalmol."},{"key":"58080_CR10","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/j.1468-1331.2008.02207.x","volume":"15","author":"TW Kim","year":"2008","unstructured":"Kim, T. W., Choung, H. K., Khwarg, S. I., Hwang, J. M. & Yang, H. J. Obesity may not be a risk factor for idiopathic intracranial hypertension in Asians. Eur J Neurol. 15, 876\u2013879 (2008).","journal-title":"Eur J Neurol."},{"key":"58080_CR11","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1111\/ene.13739","volume":"25","author":"G McCluskey","year":"2018","unstructured":"McCluskey, G. et al. Meta-analysis and systematic review of population-based epidemiological studies in idiopathic intracranial hypertension. Eur J Neurol. 25, 1218\u20131227 (2018).","journal-title":"Eur J Neurol."},{"key":"58080_CR12","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1111\/aos.13473","volume":"95","author":"Q Chen","year":"2017","unstructured":"Chen, Q. et al. High-resolution transbulbar ultrasonography helping differentiate intracranial hypertension in bilateral optic disc oedema patients. Acta Ophthalmol. 95, e481\u2013e485 (2017).","journal-title":"Acta Ophthalmol."},{"key":"58080_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0594-3","volume":"16","author":"P Lochner","year":"2016","unstructured":"Lochner, P. et al. Feasibility and usefulness of ultrasonography in idiopathic intracranial hypertension or secondary intracranial hypertension. BMC Neurol. 16, 85 (2016).","journal-title":"BMC Neurol."},{"key":"58080_CR14","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.ajem.2016.02.012","volume":"34","author":"E Komut","year":"2016","unstructured":"Komut, E. et al. Bedside sonographic measurement of optic nerve sheath diameter as a predictor of intracranial pressure in ED. Am J Emerg Med. 34, 963\u2013967 (2016).","journal-title":"Am J Emerg Med."},{"key":"58080_CR15","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00381-015-3001-2","volume":"32","author":"M Steinborn","year":"2016","unstructured":"Steinborn, M. et al. High resolution transbulbar sonography in children with suspicion of increased intracranial pressure. Childs Nerv Syst. 32, 655\u2013660 (2016).","journal-title":"Childs Nerv Syst."},{"key":"58080_CR16","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1007\/s00134-008-1149-x","volume":"34","author":"T Geeraerts","year":"2008","unstructured":"Geeraerts, T., Merceron, S., Benhamou, D., Vigu\u00e9, B. & Duranteau, J. Non-invasive assessment of intracranial pressure using ocular sonography in neurocritical care patients. Intensive Care Med. 34, 2062\u20132067 (2008).","journal-title":"Intensive Care Med."},{"key":"58080_CR17","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.ophtha.2015.06.003","volume":"122","author":"Optical coherence tomography substudy committee","year":"2015","unstructured":"Optical coherence tomography substudy committee. NORDIC idiopathic intracranial hypertension study group. Papilledema outcomes from the optical coherence tomography substudy of the idiopathic intracranial hypertension treatment trial. Ophthalmology. 122, 1939\u20131945.e2 (2015).","journal-title":"Ophthalmology."},{"key":"58080_CR18","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1001\/archophthalmol.2010.94","volume":"128","author":"CJ Scott","year":"2010","unstructured":"Scott, C. J., Kardon, R. H., Lee, A. G., Fris\u00e9n, L. & Wall, M. Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale. Arch Ophthalmol. 128, 705\u2013711 (2010).","journal-title":"Arch Ophthalmol."},{"key":"58080_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1080\/01658107.2018.1476558","volume":"43","author":"G Athappilly","year":"2018","unstructured":"Athappilly, G. et al. Ganglion cell complex analysis as a potential indicator of early neuronal loss in idiopathic intracranial hypertension. Neuroophthalmology. 43, 10\u201317 (2018).","journal-title":"Neuroophthalmology."},{"key":"58080_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/WNO.0000000000000379","volume":"36","author":"JJ Chen","year":"2016","unstructured":"Chen, J. J. & Trobe, J. D. Optical coherence tomography should be used routinely to monitor patients with idiopathic intracranial hypertension. J Neuroophthalmol. 36, 453\u2013459 (2016).","journal-title":"J Neuroophthalmol."},{"key":"58080_CR21","first-page":"1","volume":"854","author":"Physical status: the use and interpretation of anthropometry","year":"1995","unstructured":"Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 854, 1\u2013452 (1995).","journal-title":"World Health Organ Tech Rep Ser."},{"key":"58080_CR22","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1212\/WNL.0b013e3181e0f838","volume":"74","author":"BB Bruce","year":"2010","unstructured":"Bruce, B. B. et al. Atypical idiopathic intracranial hypertension: normal BMI and older patients. Neurology. 74, 1827\u20131832 (2010).","journal-title":"Neurology."},{"key":"58080_CR23","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1212\/01.wnl.0000304746.92913.dc","volume":"70","author":"BB Bruce","year":"2008","unstructured":"Bruce, B. B., Preechawat, P., Newman, N. J., Lynn, M. J. & Biousse, V. Racial differences in idiopathic intracranial hypertension. Neurology. 70, 861\u2013867 (2008).","journal-title":"Neurology."},{"key":"58080_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1196\/annals.1290.006","volume":"997","author":"DA Driscoll","year":"2003","unstructured":"Driscoll, D. A. Polycystic ovary syndrome in adolescence. Ann N Y Acad Sci. 997, 49\u201355 (2003).","journal-title":"Ann N Y Acad Sci."},{"key":"58080_CR25","first-page":"708042","volume":"2012","author":"I Avisar","year":"2012","unstructured":"Avisar, I., Gaton, D. D., Dania, H. & Stiebel-Kalish, H. The prevalence of polycystic ovary syndrome in women with idiopathic intracranial hypertension. Scientifica (Cairo). 2012, 708042 (2012).","journal-title":"Scientifica (Cairo)."},{"key":"58080_CR26","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.2337\/dc06-0877","volume":"29","author":"JC Lo","year":"2006","unstructured":"Lo, J. C. et al. Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: a population-based study. Diabetes Care. 29, 1915\u20131917 (2006).","journal-title":"Diabetes Care."},{"key":"58080_CR27","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S0161-6420(01)00987-3","volume":"109","author":"AG Lee","year":"2013","unstructured":"Lee, A. G. et al. Sleep apnea and intracranial hypertension in men.\u00a0Ophthalmology.\u00a0109, 482\u2013485 (2002).","journal-title":"Ophthalmology."},{"key":"58080_CR28","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1007\/s00415-013-6858-6","volume":"260","author":"MJ Thurtell","year":"2013","unstructured":"Thurtell, M. J. et al. Obstructive sleep apnea in idiopathic intracranial hypertension: comparison with matched population data.\u00a0J Neurol.\u00a0260, 1748\u20131751 (2013).","journal-title":"J Neurol."},{"key":"58080_CR29","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1007\/s00415-017-8532-x","volume":"264","author":"P Albrecht","year":"2017","unstructured":"Albrecht, P. et al. Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension.\u00a0J Neurol.\u00a0264, 1370\u20131380 (2017).","journal-title":"J Neurol."},{"key":"58080_CR30","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1167\/iovs.15-16450","volume":"56","author":"JJ Chen","year":"2015","unstructured":"Chen, J. J. et al. Causes and prognosis of visual acuity loss at the time of initial presentation in idiopathic intracranial hypertension. Invest Ophthalmol Vis Sci. 56, 3850\u20133859 (2015).","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"58080_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/WNO.0b013e31823f852d","volume":"33","author":"AJ Szewka","year":"2013","unstructured":"Szewka, A. J., Bruce, B. B., Newman, N. J. & Biousse, V. Idiopathic intracranial hypertension: relation between obesity and visual outcomes.\u00a0J Neuroophthalmol.\u00a033, 4\u20138 (2013).","journal-title":"J Neuroophthalmol."},{"key":"58080_CR32","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/head.13144","volume":"57","author":"SV Smith","year":"2017","unstructured":"Smith, S. V. & Friedman, D. I. The idiopathic intracranial hypertension treatment trial: a review of the outcomes. Headache.\u00a057, 1303\u20131310 (2017).","journal-title":"Headache."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58080-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58080-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58080-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T05:52:26Z","timestamp":1670305946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58080-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,27]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["58080"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-58080-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2020,1,27]]},"assertion":[{"value":"19 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1222"}}